Post-Approval Commercialization
Find presenter-approved materials from the Post-Approval Commercialization ASGCT Pre-Meeting Workshop
The Post-Approval Commercialization Workshop includes sessions on patient focused drug development; post-approval change management and overall impact on commercialization; and pricing, reimbursement, and payment models for gene therapies.
2019 Workshop Materials
Ron Bartek—Friedreich’s Ataxia Research Alliance (FARA)
Philip Reilly M.D., J.D.—Third Rock Ventures
Jugna Shah, MPH—Nimitt Consulting
William Smith, Ph.D.—Visiting Fellow in Life Sciences Pioneer Institute
Ramjay S. Vatsan, Ph.D., CQA—FDA CBER
Celia M. Witten, Ph.D., M.D.—FDA CBER